Subscribe to our Newsletters !!
In molecular biology, the LAMP (Loop-Mediated Isot
Pharmaceutical laboratories have been adopting imm
Generally, a debate about Isopure protein and regu
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
In a world constantly in motion, Microbioz India r
Hyderabad, Oct 22 (PTI) The CSIR-Centre for Cellular and Molecular Biology has set in motion the procedure for development of a COVID-19 vaccine candidate as part of a pact with Aurobindo Pharma, a top official of the premier institute said on Thursday. It had been in the process of creating a proof of concept for the vaccine candidate using three platforms and this might take four to five months, CCMB Director Rakesh K Mishra said. “We are working on some new platforms for vaccine and after we have the proof of concept ready, then we’ll hand it over to Aurobindo Pharma for additional (process).
This is something we’ve discussed with them. We dont need to work on vaccine unless there is an industry partner, Mishra told PTI. Three CSIR labs — CCMB-Hyderabad, the Institute of Medical Technology (IMTECH) at Chandigarh and the Indian Institute of Chemical Biology (IICB) at Kolkata — are growing vaccine candidates using different technology platforms. Aurobindo will treat clinical development and commercialisation of this vaccine, a media release from the CCMB had said .
We came together and Aurobindo is interacting with us and other CSIR labs saying that if you (CSIR labs) come up with proof of concept then we will have the ability to take it forward and financially support, ” he said. Meanwhile, a press release from CCMB on Thursday said Clone Deals, a city-based start-up incubated in the Atal Incubation Centre- CCMB, has developed CoronAid a book nutraceutical to improve immunity against COVID- 19.
The food supplement is made of a mushroom, Cordyceps militaris that develops in the Himalayan region and is known for its immune boosting and antioxidant components, the release stated. The startup has tied up with Ambrosia Food Company here to develop a combination of the mushroom powder with curcumin, an active ingredient in turmeric to make CoronAid Anti-Viral Immunity Booster Oral Suspension. CoronAid is exclusively marketed globally by Nuzen Herbals Private Limited, Hyderabad, according to the release. PTI GDK VS VS
